Roughly 100 patients treated with the scopes at nearly 40 VA centers between 2010 and 2015 tested positive for carbapenem-resistant Enterobacteriaceae. Officials say they can’t rule out the possibility that the devices may have been a factor in at least a dozen of those cases, though the likelihood is very low.
Additionally, VA officials conducted an analysis of more than 40,000 patient records and reported they found no widespread evidence of a problem, concluding that “any transmission appears highly unlikely,” according to the report.
The investigation results were released in response to a public-records request by The Seattle Times.
More articles on superbug infections:
FDA releases new guidance for cleaning ‘unsafe’ scopes
State investigators criticize Virginia Mason response to superbug outbreak
Researchers develop most sensitive superbug-detection test yet
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
